Hamlet BioPharma AB (publ) (XSAT:HAMLET.B)
6.08
+0.10 (1.67%)
At close: Sep 30, 2026
| Market Cap | 1.13B +13.3% |
| Revenue (ttm) | 1.62K -99.2% |
| Net Income | -54.96M |
| EPS | n/a |
| Shares Out | 186.18M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,907 |
| Open | 5.90 |
| Previous Close | 5.98 |
| Day's Range | 5.90 - 6.41 |
| 52-Week Range | 4.00 - 8.96 |
| Beta | 0.35 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 11, 2027 |